Table 3.
Reporting quality assessment of the treatment studies based upon the ARRIVE guidelines.
| Study | ARRIVE Guideline |
|||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Introduction |
Methods |
Results |
Discussion |
|||||||||||||||||||||||||||||||||||
| Title | Abstract | Back ground |
Objec tives | Ethical statement | Study design |
Experimental procedure |
Experimental animals |
Housing/ husbandry |
Sample size |
Allocating animals to experimental groups |
Experimental outcomes | Statistical methods |
Baseline data | Numbers analyzed |
Outcomes and estimation | Adverse events |
Interpretation/scientific implications |
Generalizability / Translation | Funding | |||||||||||||||||||
| a | b | a | b | c | a | b | c | d | a | b | a | b | c | a | b | c | a | b | a | b | c | a | b | a | b | a | b | c | ||||||||||
| Du 26 | F | P | F | F | F | F | F | P | P | F | P | P | N | F | P | F | F | N | F | N | NA | P | N | F | P | F | N | P | F | NA | F | N | N | F | F | P | F | F |
| Liu 33 | F | P | F | F | F | F | F | F | F | F | F | F | F | F | F | F | F | N | F | N | NA | F | N | F | F | F | N | P | F | P | P | N | N | F | F | N | F | F |
| Wang 27 | F | P | P | P | F | N | F | F | P | F | P | F | N | F | F | P | P | N | F | N | NA | P | N | F | P | F | N | F | F | NA | F | N | N | F | N | N | P | F |
| Wang 28 | F | P | P | P | F | N | F | F | P | F | F | F | N | F | F | N | N | N | F | N | NA | P | N | F | P | F | N | P | F | NA | F | N | N | F | N | N | P | F |
| Wang 29 | F | P | P | P | F | F | F | P | P | F | F | F | F | F | F | P | P | N | F | N | NA | P | N | F | F | F | N | F | F | F | F | N | N | F | N | N | P | F |
| Jiang31 | F | P | P | P | F | F | F | F | P | F | F | F | F | F | F | F | P | P | F | N | NA | P | N | F | F | F | N | N | F | F | F | N | N | F | N | N | P | F |
| Wang 34 | F | P | F | P | F | N | F | P | F | F | F | F | P | F | F | F | P | P | F | N | NA | F | N | F | F | F | N | N | F | F | F | N | N | P | N | N | P | F |
| Wang 37 | F | P | F | P | F | N | F | F | F | F | F | F | N | F | F | F | P | P | F | N | NA | F | N | F | F | F | N | N | F | F | F | N | N | P | N | N | N | F |
| Zhu 30 | F | P | F | P | F | F | F | P | F | F | F | F | N | P | F | P | P | N | F | N | NA | F | N | F | F | F | N | P | F | F | F | N | N | F | N | N | N | F |
| Wang 35 | F | P | F | P | F | N | F | P | F | F | F | F | N | F | F | F | N | N | F | F | NA | F | N | F | NA | F | N | P | F | F | F | N | N | F | N | N | N | F |
| Weilan38 | F | P | F | P | F | F | F | P | F | F | F | F | N | F | F | F | F | P | F | N | NA | F | N | F | F | F | N | P | F | F | F | N | N | F | N | N | P | F |
| Luo 40 | F | P | F | P | F | N | F | F | F | F | F | F | N | F | F | F | F | P | F | N | NA | F | N | F | F | F | N | F | F | F | F | N | N | F | P | N | P | F |
| Zhang 36 | F | P | F | P | F | N | F | F | F | F | F | F | N | F | F | F | P | P | F | N | NA | F | N | F | F | F | N | F | F | F | F | N | N | F | P | N | P | F |
| Xiao 7 | F | P | F | P | F | N | F | P | F | F | F | F | N | F | F | P | F | P | F | N | NA | F | N | F | F | F | N | P | F | F | F | N | N | F | F | N | P | F |
| Yu 32 | F | F | F | P | F | N | F | F | F | F | F | F | N | F | F | P | F | N | F | N | NA | F | N | F | F | F | N | P | F | NA | F | N | N | F | F | N | P | F |
| Zhu 39 | F | F | F | P | F | F | F | F | F | F | F | F | N | F | F | P | F | N | F | N | NA | F | N | F | F | F | F | F | F | F | F | N | N | F | F | N | P | F |
Abbreviations: ARRIVE, Animal Research: Reporting In Vivo Experiments; F, fully reported; P, partially reported; N, not reported; NA, not applicable.